Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001601830-26-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-17 | RXRX | Taylor Ben R | CFO | F - Tax | $3.49 | -11.9K | 1.21M | -1.0% | -$41.6K | |
| 2026-02-19 | 2026-02-18 | RXRX | Taylor Ben R | CFO | S - Sale | $3.08 | -13.4K | 1.20M | -1% | -$41.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-17 | F | D | 11,908 | $3.49 | 1,208,775 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-02-18 | S | D | 13,426 | $3.08 | 1,195,349 | D | — | — |